ARCHIVES

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

This article is from The Cancer Letter archive.

Vol. 35 No. 41 | November 6, 2009

Download PDF Visit The Full Archive

Related Articles

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014

List of 100 Highest-Paid NIH Officials

February 12, 2010

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Henderson Committee Final Recommendation Made On P01s

February 10, 1984